Real-world experience of 12-week direct-acting antiviral regimen of glecaprevir and pibrentasvir in patients with chronic hepatitis C virus infection.
J Gastroenterol Hepatol
; 35(5): 855-861, 2020 May.
Article
in En
| MEDLINE
| ID: mdl-31609495
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Pyrrolidines
/
Quinoxalines
/
Sulfonamides
/
Benzimidazoles
/
Hepatitis C, Chronic
Type of study:
Clinical_trials
/
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Asia
Language:
En
Journal:
J Gastroenterol Hepatol
Journal subject:
GASTROENTEROLOGIA
Year:
2020
Type:
Article
Affiliation country:
Japan